Author information: (1)Division of CLL. Department of Internal Medicine III, Ulm University, Ulm, Germany. julien.broseus@univ-lorraine.fr. (2)Inserm UMRS1256 Nutrition-Génétique et Exposition aux Risques Environnementaux (N-GERE), Université de Lorraine, Nancy, France. julien.broseus@univ-lorraine.fr. (3)Université de Lorraine, CHRU-Nancy, Service d'Hématologie Biologique, Pôle Laboratoires, F54000, Nancy, France. julien.broseus@univ-lorraine.fr. (4)Inserm UMRS1256 Nutrition-Génétique et Exposition aux Risques Environnementaux (N-GERE), Université de Lorraine, Nancy, France. (5)Institute of Human Genetics, Ulm University & Ulm University Medical Center, Ulm, Germany. (6)Division of CLL. Department of Internal Medicine III, Ulm University, Ulm, Germany. (7)Fraunhofer Institute for Cell Therapy and Immunology IZI, Leipzig, Germany. (8)Department of Haematology, University Hospital of Tours, Tours, France. (9)Department of Hematology, Hôpital de la Pitié-Salpêtrière, AP-HP, Paris, France. (10)Université de Reims Champagne-Ardenne, IRMAIC, Centre Hospitalier Universitaire de Reims, Hématologie Clinique, Reims, France. (11)Department of Hematology, University Hospital of Nancy, Vandoeuvre-lès-Nancy, France. (12)Inserm, CHRU, University of Lorraine, CIC Clinical Epidemiology, Nancy, France. (13)Department of Clinical Pathology, Robert-Bosch-Krankenhaus, and Dr. Margarete Fischer-Bosch Institute for Clinical Pharmacology, Stuttgart, Germany. (14)CHU Angers, Biological Resource Center of Angers (CRB-CHU Angers), BB-0033-00038, Laboratoire d'Hématologie, Angers, France. (15)Department of Hematology, CHU Poitiers, Poitiers, France. (16)CIC1402 Inserm Poitiers, Poitiers, France. (17)Hematology Laboratory, Avicenne Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France. (18)Bioinformatics Group, Department of Computer Science and Interdisciplinary Center for Bioinformatics, Leipzig University, Leipzig, Germany. (19)Hematology department, Clermont-Ferrand University Hospital, Clermont-Ferrand, France. (20)Department of Biopathology CHRU-ICL, BBB, CHRU Nancy, Vandoeuvre-lès-Nancy, France. (21)Biological Resource Center of Nancy, BB-0033-00035, CHRU de Nancy, Nancy, France. (22)Sorbonne Université, Cytogénétique Hématologique, Hôpital Pitié-Salpêtrière, AP-HP, Paris, France. (23)Centre de Recherche des Cordeliers, INSERM, Université Sorbonne Paris Cite, Université Paris Descartes, Université Paris Diderot, F-75006, Paris, France. (24)CHRU of Nancy, Service de Biochimie-Biologie Moléculaire-Nutrition, Pôle Laboratoires, F54000, Nancy, France. (25)Hematology Department, Hôpital Pitié-Salpêtrière, AP-HP, Sorbonne University, Paris, France. (26)Department of Hematology, University Hospital of Angers, Angers, France. (27)Institute of Pathology, University Hospital of Würzburg, Bavaria, Germany. (28)Hematology Biology, University Hospital of Nantes, Hôtel-Dieu, France. (29)Inserm 1232 Centre de Recherche en Cancérologie et Immunologie Nantes Angers (CRCINA), Nantes, France. (30)Department of Hematology, Hôpital Saint-Louis, Paris, France. (31)Division of Molecular Genetics, German Cancer Consortium (DKTK) and National Center for Tumor Diseases (NCT) Heidelberg, German Cancer Research Center (DKFZ), Heidelberg, Germany. (32)Biomedical Epigenomics Group, Institut d'investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain. (33)Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain. (34)Division of CLL. Department of Internal Medicine III, Ulm University, Ulm, Germany. Stephan.Stilgenbauer@uniklinik-ulm.de. (#)Contributed equally